Quotes with Resistance & Support

Market Information

Ajanta Pharma Q3 Net up 49%

This article was posted on Jan 31, 2008 and is filed under Press Releases

For the third quarter ended 31st December, 2007, Ajanta Pharma’s Sales increased by 22% to Rs.71.86 crores (Rs.59.06 crores) and Net Profit increased by 49% to Rs.3.94 crores (Rs.2.65 crores).

For the nine months ended 31st December, 2007, the Company’s Sales increased by 24% to Rs.203.17 crores (Rs.164.02 crores) while Net Profit increased by 49% to Rs.9.04 crores (Rs.6.09 crores).

During the quarter, Ajanta Pharma was conferred with “Quality Excellence Award 2007 – Silver” for formulation units with annual turnover exceeding Rs.100 crores by the Indian Drug Manufacturers’ Association for its Aurangabad facility.

Sourced From: Pressman India

Tags: calls, daytrading, free calls, intraday, tips

Note: The Credit of this post goes to the original witters of this post and not to NSEGUIDE

Similar Posts:

Email this Post to your friends

Breakouts

+ve » Positive / -ve » Negative

+ve 30 DMA 50 DMA 150 DMA 200 DMA

-ve 30 DMA 50 DMA 150 DMA 200 DMA

Latest Query

Post my query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam

Status: Awaiting reply

Market Stats

Search Our Archives

Research Desk

Stocks Trading above their 50 day moving average - DMA In Stock Research
Download free Ebooks based on Technical Analysis In Personal Training
TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
Charting Pathsala - Your guide to Techincals In Technical Analysis

Latest Investment Idea

Recent Comments

I love the market, it is my work, my play and my life - Rene Rivkin

Disclaimer

The calls given here are My Personal views, Trading or investing in stocks is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. NSEGUIDE will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal or corporate ownership, may influence or factor into an expert’s stock analysis or opinion.

All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is no guarantee of future price appreciation

Usage

The Stock calls recommended by NSEGUIDE can be used by you to invest & share it with your friends, but you are not allowed to publish it on your own or some website/blog without prior permission.

Recommend Site to your friends

Suggestions?

This is YOUR site, so if you have suggestions or feedback on how we can improve it for you, please feel free to speak up! We will try our best to keep up with it!

Make a Suggestion